May 10, 2019
BioSpecifics Technologies ends quarter with $4.4 million
BioSpecifics reported net income of $4.4 million for the first quarter 2019, compared to net income of $4.0 million, for the same period in 2018.
Pharmaceuticals, Biotechnology and Life Sciences
BioSpecifics reported net income of $4.4 million for the first quarter 2019, compared to net income of $4.0 million, for the same period in 2018.